Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-19T00:33:01.780Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacological intervention in the initial prodromal phase of psychosis

Published online by Cambridge University Press:  16 April 2020

Stephan Ruhrmann ,
Frauke Schultze-Lutter ,
Wolfgang Maier  and
Joachim Klosterkötter
Stephan Ruhrmann*
Affiliation:
Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany
Frauke Schultze-Lutter
Affiliation:
Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany
Wolfgang Maier
Affiliation:
Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany
Joachim Klosterkötter
Affiliation:
Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany
*
*Corresponding author. E-mail address: stephan.ruhrmann@uni-koeln.de (S. Ruhrmann).
Get access

Abstract

Early identification and treatment of schizophrenia may alleviate the symptoms, delay the onset and improve the outcome of psychosis. Thus, detection of individuals at risk during the prodromal phase is an important task. Universal approaches to screen the general population or healthy subjects at risk have not proven possible to-date. However, clinical criteria for detecting ultra-high risk individuals have been developed for specialized settings, with their implementation in interventional studies. This article examines the rationale for early detection and intervention of psychosis, along with a review of some of the current studies. These target prevention using psychological and/or pharmacological intervention strategies have demonstrated promising results in high risk individuals. The German Research Network on Schizophrenia (GRNS) is conducting two multicenter early intervention studies; one with early psychological intervention in subjects who manifest early prodromal symptoms; with the second trial applying clinical management and pharmacological early intervention in subjects experiencing late prodromal symptoms (high risk subjects). Despite the promising results, many of the current studies have small sample sizes with study durations of a short period. The full benefits of early detection and intervention should be revealed once larger and longer studies are conducted.

Keywords

Early interventionPsychosisProdromal phaseSchizophreniaGerman Research Network on Schizophrenia
Type
Original article
Information
European Psychiatry , Volume 20 , Issue 1 , January 2005 , pp. 1 - 6
Copyright
Copyright © Elsevier SAS 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addington, D, Addington, J, Patten, SDepression in people with first-episode schizophrenia. Br J Psychiatr 1998;172:S90–S92.CrossRefGoogle ScholarPubMed
Andreasson, S, Allebeck, P, Engstrom, A, Rydberg, UCannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lance 1987;2:1483–1486.CrossRefGoogle ScholarPubMed
Bebbington, P, Wilkins, S, Jones, P, Foerster, A, Murray, R, Toone, Bet al.Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. Br J Psychiatr 1993;162:72–79.CrossRefGoogle ScholarPubMed
Berger, GE, Wood, S, McGorry, PDIncipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacol Bul 2003;37:79–101.Google ScholarPubMed
Birchwood, M, McMillan, JFEarly intervention in schizophrenia. Aust N Z J Psychiatr 1993;27:374–378.CrossRefGoogle Scholar
Boydell, J, Van Os, J, McKenzie, K, Allardyce, J, Goel, R, McCreadie, RGet al.Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. Br Med 2001;323:1336–1338.CrossRefGoogle ScholarPubMed
Brown, S, Birtwistle, JPeople with schizophrenia and their families. Fifteen-year outcome. Br J Psychiatr 1998;173:139–144.CrossRefGoogle ScholarPubMed
Bruce, ML, Takeuchi, DT, Leaf, PJPoverty and psychiatric status. Longitudinal evidence from the New Haven Epidemiologic Catchment Area study. Arch Gen Psychiatr 1991;48:470–474.CrossRefGoogle ScholarPubMed
Cornblatt, BAThe New York high risk project to the Hillside recognition and prevention (RAP) program. Am J Med Gene 114 2002 956–956CrossRefGoogle ScholarPubMed
Cornblatt, BA, Lencz, T, Smith, CW, Correll, CU, Auther, AM, Nakayama, EThe schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bul 2003;29:633–651.CrossRefGoogle ScholarPubMed
DeGrazia, DEthical issues in early-intervention clinical trials involving minors at risk for schizophrenia. Schizophr Re 2001;51:77–86.CrossRefGoogle ScholarPubMed
Gottesman, IISchizophrenia epigenesis: past, present, and future. Acta Psychiatr Scand 1994;384:S26–S33.CrossRefGoogle ScholarPubMed
Haas, GL, Garratt, LS, Sweeney, JADelay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J Psychiatr Res 1998;32:151–159.CrossRefGoogle ScholarPubMed
Hambrecht, M, Häfner, HCannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust New Zealand J Psychiatr 2000;34:468–475.CrossRefGoogle Scholar
Hambrecht, M, Lammertink, M, Klosterkötter, J, Matuschek, E, Pukrop, RSubjective and objective neuropsychological abnormalities in a psychosis prodrome clinic. Br J Psychiatry Supp 2002;43:S30–S37.CrossRefGoogle Scholar
Heinssen, RK, Perkins, DO, Appelbaum, PS, Fenton, WSInformed consent in early psychosis research: National Institute of Mental Health Workshop, November 15, 2000. Schizophr Bul 2001;27:563–570.Google ScholarPubMed
Helgason, LTwenty years’ follow-up of first psychiatric presentation for schizophrenia: what could have been prevented?. Acta Psychiatr Scand 1990;81:231–235.CrossRefGoogle ScholarPubMed
Huber, GReine Defektsyndrome und Basisstadien endogener Psychosen. Fortschr Neurol Psychiatr 1966;34:409–426.Google Scholar
Humphreys, MS, Johnstone, EC, MacMillan, JF, Taylor, PJDangerous behaviour preceding first admissions for schizophrenia. Br J Psychiatr 1992;161:501–505.CrossRefGoogle Scholar
Häfner, H, Nowotny, BEpidemiology of early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 1995;245:80–92.CrossRefGoogle ScholarPubMed
Häfner, H, Löffler, W, Maurer, K, Hambrecht, M, Der Heiden, WDepression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 1999;100:105–108.CrossRefGoogle ScholarPubMed
Häfner, H, Maurer, K, Ruhrmann, S, Bechdolf, A, Klosterkötter, J, Wagner, Met al.Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosc 2004;254:117–128.CrossRefGoogle ScholarPubMed
Jablensky, AThe 100-year epidemiology of schizophrenia. Schizophr Res 1997;28:111–125.CrossRefGoogle ScholarPubMed
Johannessen, JO, McGlashan, TH, Larsen, TK, Horneland, M, Joa, I, Mardal, Set al.Early detection strategies for untreated first-episode psychosis. Schizophr Re 2001;51:39–46.CrossRefGoogle ScholarPubMed
Johnstone, EC, Crow, TJ, Johnson, AL, McMillan, JFThe Northwick Park study of first episodes of schizophrenia: I. Presentation of the illness and problems relating to admission. Br J Psychiatr 1986;148:115–120.CrossRefGoogle Scholar
Kane, JM, Krystal, J, Corell, CUTreatment models and designs for intervention research during the psychotic prodrome. Schizophr Bul 2003;29:747–756.CrossRefGoogle ScholarPubMed
Klosterkötter, J, Schultze-Lutter, FIs there a primary prevention of schizophrenic psychiosis?. Fortschr Neurol Psychiat 2001;69:S104–S112[Article in German]CrossRefGoogle Scholar
Kolakowska, T, Williams, AO, Ardern, M, Reveley, MA, Jambor, K, Gelder, MGet al.Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction. Br J Psychiatr 1985;146:229–239.CrossRefGoogle ScholarPubMed
Koreen, AR, Siris, SG, Chakos, M, Alvir, J, Mayerhoff, D, Lieberman, JDepression in first-episode schizophrenia. Am J Psychiatr 1993;150:1643–1648.Google ScholarPubMed
Larsen, TK, Johannessen, JO, Opjordsmoen, SFirst-episode schizophrenia with long duration of untreated psychosis. Pathways to care. Br J Psychiatr 1998;172:S45–S52.CrossRefGoogle ScholarPubMed
Lieberman, JA, Sheitman, BB, Kinon, BJEndogenous neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neural regulation and plasticity. Neuropsychopharmacolog 1997;17:205–209.CrossRefGoogle Scholar
Lieberman, JA, Perkins, D, Belger, A, Chakos, M, Jarskog, F, Boteva, Ket al.The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatr 2001;50:884–897.CrossRefGoogle ScholarPubMed
Loebel, AD, Lieberman, JA, Alvir, JM, Mayerhoff, DI, Geisler, SH, Szymanski, SRDuration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatr 1992;149:1183–1188.Google ScholarPubMed
McGlashan, THPsychosis treatment prior to psychosis onset: ethical issues. Schizophr Re 2001;51:47–54.CrossRefGoogle ScholarPubMed
McGlashan TH. Abstract presented at the Twelfth Biennial Winter Workshop on Schizophrenia. Davos, Switzerland, 7–13 February 2004.Google Scholar
McGorry, PD, Edwards, J, Mihalopoulos, C, Harrigan, SM, Jackson, HJEPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996;22:305–326.CrossRefGoogle ScholarPubMed
McGorry, PD, Yung, AR, Phillips, LJ, Yuen, HP, Francey, S, Cosgrave, EMet al.Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatr 2002;59:921–928.CrossRefGoogle Scholar
McGorry, PD, Yung, AR, Phillips, LJThe “close-in” or ultra high-risk model: A safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bul 2003;29:771–790.CrossRefGoogle ScholarPubMed
McGrath, J, Saha, S, Welham, J, El Saadi, O, MacCauley, C, Chant, Det al.A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Me 2004;2:13CrossRefGoogle ScholarPubMed
McGue, M, Gottesman, IIThe genetic epidemiology of schizophrenia and the design of linkage studies. Eur Arch Psychiatry Clin Neurosci 1991;240:174–181.CrossRefGoogle ScholarPubMed
Miller, P, Lawrie, SM, Hodges, A, Clafferty, R, Cosway, R, Johnstone, ECGenetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc Psychiatry Psychiatr Epidemio 2001;36:338–342.CrossRefGoogle ScholarPubMed
Miller, TJ, Zipursky, RB, Perkins, D, Addington, J, Woods, SW, Hawkins, KAet al.The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the “prodromal” sample. Schizophr Re 2003;61:19–30.CrossRefGoogle ScholarPubMed
O’Callaghan, E, Gibson, T, Colohan, HA, Buckley, P, Walshe, DG, Larkin, Cet al.Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. BM 1992;305:1256–1259.CrossRefGoogle ScholarPubMed
Phillips, LJ, Yung, AR, McGorry, PDIdentification of young people at risk of psychosis: validation of personal assessment and crisis evaluation clinic intake criteria. Aust New Zealand J Psychiatr 2000;34:S164–S169.CrossRefGoogle ScholarPubMed
Pollack, M, Woerner, MG, Goodman, W, Greenberg, IMChildhood development patterns of hospitalized adult schizophrenic and non-schizophrenic patients and their siblings. Am J Orthopsychiatr 1966;36:510–517.CrossRefGoogle Scholar
Ruhrmann, S, Schultze-Lutter, F, Klosterkötter, JEarly detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatr 2003;36:S162–S167.Google ScholarPubMed
Ruhrmann, S, Schultze-Lutter, F, Von Reventlow, H, Picker, H, Tschinkel, S, Bühler, Bet al.Functional disability in the prodromal phase of psychosis. Eur Psychiatr 2004;19:S11Google Scholar
Schultze-Lutter, FPrediction of psychosis is necessary and possible. McDonald, C, Schulze, K, Murray, R, Wright, PSchizophrenia: challenging the orthodo London, New York: Taylor & Francis; 2004. 81–90.Google Scholar
Selten, JP, Slaets, JP, Kahn, RSSchizophrenia in Surinamese and Dutch Antillean immigrants to The Netherlands: evidence of an increased incidence. Psychol Med 1997;27:807–811.CrossRefGoogle ScholarPubMed
Sham, PC, O’Callaghan, E, Takei, N, Murray, GK, Hare, EH, Murray, RMSchizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatr 1992;160:461–466.CrossRefGoogle ScholarPubMed
Stirling, J, Tantam, D, Thomas, P, Newby, D, Montague, L, Ring, Net al.Expressed emotion and early onset schizophrenia: a 1 year follow-up. Psychol Med 1991;21:675–685.CrossRefGoogle Scholar
Strakowski, SM, Keck, PE Jr., McElroy, SL, Lonczak, HS, West, SAChronology of comorbid and principal syndromes in first-episode psychosis. Compr Psychiatr 1995;36:106–112.CrossRefGoogle ScholarPubMed
Strous, RD, Alvir, JM, Robinson, D, Gal, G, Sheitman, B, Chakos, Met al.Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects. Schizophr Bul 2004;30:265–278.CrossRefGoogle ScholarPubMed
Susser, E, Neugebauer, R, Hoek, HW, Brown, AS, Lin, S, Labovitz, Det al.Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatr 1996;53:25–31.CrossRefGoogle ScholarPubMed
Woods, SW, Miller, TJ, McGlashan, THThe ‘prodromal’ patient: Both, symptomatic and at risk. CNS Spect 2001;6:223–232.CrossRefGoogle ScholarPubMed
Woods, SW, Breier, A, Zipursky, RB, Perkins, DO, Addington, J, Miller, TJet al.Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatr 2003;54: 453–464.CrossRefGoogle ScholarPubMed
Wölwer, W, Buchkremer, G, Häfner, H, Klosterkotter, J, Maier, W, Moller, HJet al.German research network on schizophrenia-bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci 2003;253: 321–329.CrossRefGoogle ScholarPubMed
Yung, AR, Phillips, LJ, McGorry, PD, McFarlane, CA, Francey, S, Harrigan, Set al.Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br. J. Psychiatry Suppl. 1998;172: S14–S20.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.